Edition:
United States

Shire PLC (SHPG.OQ)

SHPG.OQ on NASDAQ Stock Exchange Global Select Market

134.06USD
16 Feb 2018
Change (% chg)

$-1.24 (-0.92%)
Prev Close
$135.30
Open
$135.38
Day's High
$136.05
Day's Low
$133.51
Volume
381,275
Avg. Vol
427,056
52-wk High
$192.15
52-wk Low
$123.73

Latest Key Developments (Source: Significant Developments)

Shire Announces FDA Acceptance Of sBLA For Cinryze For Pediatric Hereditary Angioedema Use
Thursday, 15 Feb 2018 07:00am EST 

Feb 15 (Reuters) - Shire Plc ::SHIRE ANNOUNCES FDA ACCEPTANCE OF SBLA FOR CINRYZE® FOR PEDIATRIC HEREDITARY ANGIOEDEMA USE.SHIRE PLC - FILING HAS RECEIVED PRIORITY REVIEW DESIGNATION FROM FDA.SHIRE PLC - FDA EXPECTED TO PROVIDE DECISION ON EXPANDED INDICATION OF CINRYZE BY JUNE 20, 2018, BASED ON PDUFA V ACTION DAT.  Full Article

Shire Says Granted Orphan Drug Status For Crohn's Disease Treatment For Children
Tuesday, 13 Feb 2018 07:00am EST 

Feb 13 (Reuters) - Shire Plc ::SHIRE - U.S. FDA GRANTS ORPHAN DRUG DESIGNATION FOR INVESTIGATIONAL SHP647 FOR TREATMENT OF PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE.SHIRE - HEALTH CANADA GRANTS PRIORITY REVIEW FOR INVESTIGATIONAL LANADELUMAB FOR PREVENTION OF ANGIOEDEMA ATTACKS IN OLDER PATIENTS WITH HEREDITARY ANGIOEDEMA.SHIRE PLC - PEDIATRIC STUDY PLANS WITH SHP647 ARE CURRENTLY UNDER DISCUSSION WITH HEALTH AUTHORITIES.SHIRE PLC - HEALTH CANADA REVIEW OF NDS UNDER PRIORITY REVIEW IS EXPECTED TO BE COMPLETED IN SECOND HALF OF 2018.  Full Article

Shire Says ‍Thomas Dittrich Will Assume Role As CFO
Friday, 19 Jan 2018 05:00am EST 

Jan 19 (Reuters) - Shire Plc ::‍THOMAS DITTRICH WILL ASSUME HIS ROLE AS CHIEF FINANCIAL OFFICER​.THOMAS DITTRICH WILL ASSUME ROLE AS CFO, AND BECOME EXECUTIVE MEMBER OF BOARD OF DIRECTORS AND MEMBER OF EXECUTIVE COMMITTEE, ON MARCH 19, 2018​.  Full Article

Shire Says Granted EU marketing Authorization For ADYNOVI For Adults And Adolescents With Hemophilia A
Monday, 15 Jan 2018 02:00am EST 

Jan 15 (Reuters) - Shire Plc ::SHIRE GRANTED EU MARKETING AUTHORIZATION FOR ADYNOVI [ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED] FOR ADULTS AND ADOLESCENTS WITH HEMOPHILIA A​.‍SHIRE IS NOW AUTHORIZED TO MARKET ADYNOVI IN 28 MEMBER STATES OF EUROPEAN UNION (EU), AS WELL AS IN ICELAND, LIECHTENSTEIN AND NORWAY​.  Full Article

Shire Says Xiidra Approved By Health Canada To Treat Signs And Symptoms Of Dry Eye Disease
Wednesday, 3 Jan 2018 07:00am EST 

Jan 3 (Reuters) - Shire Plc ::XIIDRA APPROVED BY HEALTH CANADA TO TREAT SIGNS AND SYMPTOMS OF DRY EYE DISEASE.XIIDRA WILL BE AVAILABLE FOR PATIENTS IN CANADA IN EARLY 2018..  Full Article

Shire Says ‍U.S. FDA Has Granted Marketing Clearance To myPKFiT
Tuesday, 19 Dec 2017 07:30am EST 

Dec 19 (Reuters) - Shire Plc ::‍U.S. FOOD AND DRUG ADMINISTRATION HAS GRANTED 510(K) MARKETING CLEARANCE TO MYPKFIT FOR ADVATE​.  Full Article

Shire Plc Appoints ‍John Miller As Interim CFO
Friday, 8 Dec 2017 11:18am EST 

Dec 8 (Reuters) - Shire PLC ::SHIRE PLC SAYS ‍JOHN MILLER TO SERVE AS INTERIM CFO WITH EFFECT FROM JAN 1, 2018 UNTIL THOMAS DITTRICH COMMENCES HIS EMPLOYMENT WITH CO - SEC FILING​.SAYS ‍MILLER ENTERED NEW LETTER AGREEMENT WITH CO PURSUANT TO WHICH HIS ANNUAL BASE SALARY TO INCREASE TO $765,000​ WHILE SERVING AS INTERIM CFO.  Full Article

Shire And Rani Therapeutics enter into collaboration to evaluate use of the Rani Pill technology
Tuesday, 5 Dec 2017 07:00am EST 

Dec 5 (Reuters) - Shire Plc ::SHIRE AND RANI THERAPEUTICS ENTER INTO COLLABORATION TO EVALUATE USE OF THE RANI PILL(TM) TECHNOLOGY FOR THE ORAL DELIVERY OF FACTOR THERAPY.- AS PART OF COLLABORATION, SHIRE HAS ALSO MADE AN EQUITY INVESTMENT INTO RANI THERAPEUTICS.SAYS SPECIFIC TERMS OF THIS DEAL WERE NOT DISCLOSED.  Full Article

Shire names Thomas Dittrich as CFO
Monday, 20 Nov 2017 08:01am EST 

Nov 20 (Reuters) - Shire Plc :Shire Plc <<>> says Thomas Dittrich will join company as chief financial officer​.Shire Plc <<>> says Thomas Dittrich will assume his role as CFO in early 2018 following a transition period from his current employer​.  Full Article

Omega Advisors dissolves share stake in Carrizo Oil & Gas, ups in Shire PLC
Tuesday, 14 Nov 2017 12:53pm EST 

Nov 14 (Reuters) - Omega Advisors Inc::Omega Advisors Inc dissolves share stake in Carrizo Oil & Gas Inc - SEC Filing‍​.Omega Advisors Inc raises share stake in Shire PLC by about 31 percent to 653,977 sponsored ADRs.Omega Advisors Inc - Change in holdings are as of Sept 30, 2017 and compared with the previous quarter ended as of June 30, 2017.  Full Article

BRIEF-Shire Announces FDA Acceptance Of sBLA For Cinryze For Pediatric Hereditary Angioedema Use

* SHIRE ANNOUNCES FDA ACCEPTANCE OF SBLA FOR CINRYZE® FOR PEDIATRIC HEREDITARY ANGIOEDEMA USE